Author Affiliations
- Yoshinobu Maeda1,*⇑,
- Tomotaka Ugai2,3,*,
- Eisei Kondo4,
- Kazuhiro Ikegame5,
- Makoto Murata6,
- Naoyuki Uchida7,
- Toshihiro Miyamoto8,
- Satoshi Takahashi9,
- Kazuteru Ohashi10,
- Hirohisa Nakamae11,
- Takahiro Fukuda12,
- Makoto Onizuka13,
- Tetsuya Eto14,
- Shuichi Ota15,
- Makoto Hirokawa16,
- Tatsuo Ichinohe17,
- Yoshiko Atsuta18,
- Yoshinobu Kanda3,19 and
- Junya Kanda20
- on behalf of the HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation
- 1Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya
- 3Division of Hematology, Saitama Medical Center, Jichi Medical University, Tochigi
- 4Division of Hematology, Department of Medicine, Kawasaki Medical School, Okayama
- 5Division of Hematology, Department of Internal Medicine, Hyogo Medical College
- 6Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
- 7Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo
- 8Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka
- 9Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo
- 10Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo
- 11Department of Hematology, Osaka City University Hospital
- 12Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo
- 13Department of Hematology/Oncology, Tokai University School of Medicine, Kanagawa
- 14Department of Hematology, Hamanomachi Hospital, Fukuoka
- 15Department of Hematology, Sapporo Hokuyu Hospital, Hokkaido
- 16Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine
- 17Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University
- 18Department of Healthcare Administration, Nagoya University Graduate School of Medicine
- 19Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi
- 20Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan
- Correspondence
: YOSHINOBU MAEDA yosmaeda{at}md.okayama-u.ac.jp
Article Information
vol. 104 no. 5 1055-1061
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 20, 2018
- Accepted November 23, 2018
- .
Article Versions
- previous version (December 6, 2018 - 05:18).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright© 2019 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
Author Information
- Yoshinobu Maeda1,*⇑,
- Tomotaka Ugai2,3,*,
- Eisei Kondo4,
- Kazuhiro Ikegame5,
- Makoto Murata6,
- Naoyuki Uchida7,
- Toshihiro Miyamoto8,
- Satoshi Takahashi9,
- Kazuteru Ohashi10,
- Hirohisa Nakamae11,
- Takahiro Fukuda12,
- Makoto Onizuka13,
- Tetsuya Eto14,
- Shuichi Ota15,
- Makoto Hirokawa16,
- Tatsuo Ichinohe17,
- Yoshiko Atsuta18,
- Yoshinobu Kanda3,19 and
- Junya Kanda20
- on behalf of the HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation
- 1Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya
- 3Division of Hematology, Saitama Medical Center, Jichi Medical University, Tochigi
- 4Division of Hematology, Department of Medicine, Kawasaki Medical School, Okayama
- 5Division of Hematology, Department of Internal Medicine, Hyogo Medical College
- 6Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
- 7Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo
- 8Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka
- 9Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo
- 10Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo
- 11Department of Hematology, Osaka City University Hospital
- 12Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo
- 13Department of Hematology/Oncology, Tokai University School of Medicine, Kanagawa
- 14Department of Hematology, Hamanomachi Hospital, Fukuoka
- 15Department of Hematology, Sapporo Hokuyu Hospital, Hokkaido
- 16Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine
- 17Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University
- 18Department of Healthcare Administration, Nagoya University Graduate School of Medicine
- 19Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi
- 20Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan
- Correspondence
: YOSHINOBU MAEDA yosmaeda{at}md.okayama-u.ac.jp